Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Reeves Karen — Kiromic Biopharma, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Reeves Karen

Reeves Karen

Director at Kiromic Biopharma, Inc. · on record since May 24, 2022

Insider trading activity of Reeves Karen

Transactions on record: 1; since Jul 5, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 5, 2022

Figures computed from official regulatory filings — methodology.

Companies where Reeves Karen has traded

Kiromic Biopharma, Inc.1 tx · Jul 5, 2022

Track record of Reeves Karen

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Reeves Karen

Co-insiders of Reeves Karen

BERSANI PIETROKiromic Biopharma, Inc.
Catlin MichaelKiromic Biopharma, Inc.
Chiriva Internati MaurizioKiromic Biopharma, Inc.
Cicchetti AmericoKiromic Biopharma, Inc.
Clark Daniel GrantKiromic Biopharma, Inc.
Dahlbeck ScottKiromic Biopharma, Inc.
Hungerford BrianKiromic Biopharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Mirandola LeonardoKiromic Biopharma, Inc.

Misajon PamelaKiromic Biopharma, Inc.

NAGEL MICHAELKiromic Biopharma, Inc.

Nunez IgnacioKiromic Biopharma, Inc.

Ralston ShannonKiromic Biopharma, Inc.

Rotino GianlucaKiromic Biopharma, Inc.

Ryan Michael CharlesKiromic Biopharma, Inc.

Schneider Jerry A.Kiromic Biopharma, Inc.

Tirelli Francis XKiromic Biopharma, Inc.

Tontat TonyKiromic Biopharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kiromic Biopharma, Inc.	Jul 5, 2022	AwardD	183,600	0.00 USD	$0	SEC